Increased metastatic potential of tumor cells in von Willebrand factor-deficient mice.
about
Deadly allies: the fatal interplay between platelets and metastasizing cancer cellsPlatelet P2Y12 is involved in murine pulmonary metastasisvon Willebrand factor: more than a regulator of hemostasis and thrombosis.Gastric cancer-associated enhancement of von Willebrand factor is regulated by vascular endothelial growth factor and related to disease severity.Expression of stanniocalcin 1 in thyroid side population cells and thyroid cancer cellsThe novel desmopressin analogue [V4Q5]dDAVP inhibits angiogenesis, tumour growth and metastases in vasopressin type 2 receptor-expressing breast cancer models.Periostin Is a Key Niche Component for Wound Metastasis of Melanoma.Metastasis: recent discoveries and novel perioperative treatment strategies with particular interest in the hemostatic compound desmopressin.Platelet glycoprotein Ib alpha supports experimental lung metastasisA phase II dose-escalation trial of perioperative desmopressin (1-desamino-8-d-arginine vasopressin) in breast cancer patients.Ganoderma lucidum polysaccharides eradicates the blocking effect of fibrinogen on NK cytotoxicity against melanoma cells.Platelet GPIIb supports initial pulmonary retention but inhibits subsequent proliferation of melanoma cells during hematogenic metastasis.Cirrhosis, von Willebrand Factor (vWF) and the Low Incidence of Metastatic Malignancy in Injured Livervon-Willebrand factor influences blood brain barrier permeability and brain inflammation in experimental allergic encephalomyelitisThe role of platelet activation in tumor metastasis.Structural insights into the interactions between platelet receptors and fibrillar collagen.Heparins that block VEGF-A-mediated von Willebrand factor fiber generation are potent inhibitors of hematogenous but not lymphatic metastasis.Platelets: linking hemostasis and cancer.Canine mammary tumours, an overview.von Willebrand factor: the old, the new and the unknown.On the versatility of von Willebrand factorPlatelets in cancer metastasis: To help the "villain" to do evil.ADAM23 is downregulated in side population and suppresses lung metastasis of lung carcinoma cells.Contributions of thrombin targets to tissue factor-dependent metastasis in hyperthrombotic mice.Platelets and fibrinogen facilitate each other in protecting tumor cells from natural killer cytotoxicity.Increased von Willebrand factor over decreased ADAMTS-13 activity is associated with poor prognosis in patients with advanced non-small-cell lung cancer.High relative density of lymphatic vessels predicts poor survival in tongue squamous cell carcinoma.Functional assessment of von Willebrand factor expression by cancer cells of non-endothelial origin.The 80th anniversary of von Willebrand's disease: history, management and research.Gene expression studies demonstrate that the K-ras/Erk MAP kinase signal transduction pathway and other novel pathways contribute to the pathogenesis of cumene-induced lung tumors.ADAMTS-13 and von Willebrand factor predict venous thromboembolism in patients with cancer.Addition of vasopressin synthetic analogue [V(4)Q(5)]dDAVP to standard chemotherapy enhances tumour growth inhibition and impairs metastatic spread in aggressive breast tumour models.Alterations in NO- and PGI2- dependent function in aorta in the orthotopic murine model of metastatic 4T1 breast cancer: relationship with pulmonary endothelial dysfunction and systemic inflammation.von Willebrand factor is a useful biomarker for liver fibrosis and prediction of hepatocellular carcinoma development in patients with hepatitis B and CNovel antibodies against GPIbα inhibit pulmonary metastasis by affecting vWF-GPIbα interaction
P2860
Q24623647-130A2C75-03D9-4C8B-95A0-AD6C72450313Q28535093-507CB88E-3678-4F04-9CA8-D355EC0B5693Q33402792-CCF67984-5DC9-471D-8226-D344D0EFCDAEQ35121586-B6BCE6C2-1E5D-4999-91C2-0EF1C989496AQ35324872-AC7EFFBF-A51F-44D6-A497-0DC11443E4F6Q35636438-5FAA8DE8-D711-4D70-A337-F887ECDCD254Q35666037-8B7334B3-33F0-43D3-9943-7A92BD3A8ACFQ35671216-236E11FE-D1D7-466E-BE49-7D83F26F825FQ35829198-0481782E-9FD1-4C10-A00F-E3809C838901Q35967856-C0E1E148-3762-4337-894A-09623D8753E4Q35995996-D199441C-F070-4197-AE05-50CB11190E6CQ36295276-250729F2-296B-4118-A33D-67E1A4CA4365Q36319152-0536D726-3AE9-49A6-A0CA-8C7A9CD8C5CFQ36853655-B6831877-648F-432B-8B61-0A559C424972Q37242670-8E8A7AB7-8C16-4C17-A9F9-198EF9ADB5A3Q37463580-CA5F17EB-0F73-4598-86F8-506250DF0C95Q37708829-982D9B06-9711-4669-A34B-855808A5820EQ37808901-C12FD5F6-CAB3-4C21-BBF8-3B5C3F7FDB3AQ37885436-5A28A525-0B93-460A-8F39-438522F02D74Q38047344-9F73C709-772B-4418-B659-964D4A405530Q38128303-92700DCB-54EB-4FD3-954F-2B36B87C4B69Q38584175-B3EE4BCE-AE44-47C0-AC49-10BDF5F10B65Q38800417-8DD09F73-BA19-42FD-918B-3C4E5D38FAB2Q39068369-FAFE5000-C599-478B-AB6A-A5F0B2473E72Q39870321-042988FA-F96D-4A3E-A821-91AE7BEB0AD3Q40265635-A90516C0-F6D3-43A1-94FD-F9088477E63FQ40689187-9B4F4577-99CF-4BEB-AD30-0CC017AA818BQ41908160-FA5C046B-A229-4765-89B4-41D23EF0B7C5Q45863536-F284FF56-097C-4317-ADC5-C8DD65B7AE9FQ46468224-F20F2F8F-CC21-4163-8CE8-C51275EC41BFQ53275633-A8E8109D-A506-486C-AA5F-233F86CFE30FQ53788180-F0C1A8C5-19E5-447E-B9FA-1437C3749E67Q55081573-5B087E42-0745-4E5E-91D7-A701F24108D5Q58579645-83F952A8-76AB-4EC0-8BD7-584E52ACD17BQ58732980-14D6B50B-D2BB-4168-B8B1-FFF680947C06
P2860
Increased metastatic potential of tumor cells in von Willebrand factor-deficient mice.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
2005年论文
@zh
2005年论文
@zh-cn
name
Increased metastatic potential of tumor cells in von Willebrand factor-deficient mice.
@en
type
label
Increased metastatic potential of tumor cells in von Willebrand factor-deficient mice.
@en
prefLabel
Increased metastatic potential of tumor cells in von Willebrand factor-deficient mice.
@en
P2093
P2860
P50
P1476
Increased metastatic potential of tumor cells in von Willebrand factor-deficient mice
@en
P2093
P2860
P304
P356
10.1111/J.1538-7836.2005.01770.X
P577
2005-12-23T00:00:00Z